CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-03 | Kaye Edward M. MD CEO | Option exercise · Performance Stock Units | −26,250 | 26,250 | ||
| 2024-12-03 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +6,000 | 44,838 | ||
| 2024-12-03 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Grant or award · Performance Stock Units | +12,000 | 12,000 | ||
| 2024-12-03 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Performance Stock Units | −6,000 | 6,000 | ||
| 2024-12-03 | Kaye Edward M. MD CEO | Option exercise | +26,500 | 75,091 | ||
| 2024-12-03 | Kaye Edward M. MD CEO | Grant or award · Performance Stock Units | +53,000 | 53,000 | ||
| 2024-12-03 | Kaye Edward M. MD CEO | Option exercise · Performance Stock Units | −26,500 | 26,500 | ||
| 2024-12-03 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise | +10,000 | 61,277 | ||
| 2024-12-03 | Ticho Barry CHIEF MEDICAL OFFICER | Grant or award · Performance Stock Units | +20,000 | 20,000 | ||
| 2024-12-03 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Performance Stock Units | −10,000 | 10,000 | ||
| 2024-12-02 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +10,000 | $0.60 | $6K | 61,277 |
| 2024-12-02 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −10,000 | $12.07 | $121K | 51,277 |
| 2024-12-02 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 0 | ||
| 2024-12-01 | Kaye Edward M. MD Director | Option exercise | +4,317 | 53,441 | ||
| 2024-12-01 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +33,927 | 38,838 | ||
| 2024-12-01 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Restricted Stock Unit (RSU) | −33,927 | 12,357 | ||
| 2024-12-01 | Kaye Edward M. MD CEO | Option exercise | +21,591 | 48,591 | ||
| 2024-12-01 | Kaye Edward M. MD CEO | Option exercise · Restricted Stock Unit (RSU) | −21,591 | 4,317 | ||
| 2024-12-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +48,792 | 51,277 | ||
| 2024-12-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Unit (RSU) 10b5-1 | −48,792 | 11,981 |
Page 14 of 24 · 461 trades